Main Number of highest risk product domestic inspections in the month resulting in a category of classifications called OTHER The number of highest-risk product inspections where one of the following four outcomes occurred. 1. Referred to State for Follow-Up: the findings of the inspection were such that there is no federal jurisdiction over the apparent violation in question or it is determined that State action is the most efficient method of obtaining the establishment’s compliance with Federal laws, regulations or administrative requirements. 2. Referred to Center: the Establishment Inspection Report has been referred to the appropriate Center for a final inspection district decision. 3. Not Yet Completed by Investigator: the inspection has been completed but the investigator has not yet reported [into the database] what district decision will be recommended. 4. Not Yet Endorsed by Investigations: the investigator’s recommendation is that the district decision should be OAI but this recommendation has not yet been endorsed (reviewed and approved) by the investigator’s supervisor Number Classified as Other column 0 0 20 2010 FY 2010 Overall: 84 0 2011 FY 2011 Overall: 278 2012 FY 2012 Total: 127 Sub Number of highest risk product domestic inspections in the month resulting in a category of classifications called OTHER Percent of highest risk domestic inspections in the month resulting in a classification of Other Percent Classified as Other 2010 2011 20 2012 http://www.fda.gov/AboutFDA/Transparency/track/ucm204013.htm FDA-TRACK ORA Regional Offices Dashboard word text word defintion ਍††਍਍਍਍਍਍਍